Meeder Asset Management Inc Charles River Laboratories International, Inc. Transaction History

Meeder Asset Management Inc

$1.43 Billion
Q4 2024

A detailed history of Meeder Asset Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 27 shares of CRL stock, worth $4,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$4,064

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$178.58 - $220.69 $4,821 - $5,958	27 New	27 $4,000
Q2 2024 Aug 08, 2024	SELL	$206.39 - $268.73 $62,742 - $81,693	-304 Reduced 90.75%	31 $6,000
Q1 2024 May 07, 2024	SELL	$203.52 - $273.43 $111,121 - $149,292	-546 Reduced 61.98%	335 $90,000
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $169,055 - $228,989	881 New	881 $177,000
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $23,534 - $32,319	-129 Reduced 45.1%	157 $31,000
Q2 2022 Aug 08, 2022	SELL	$204.13 - $302.4 $27,965 - $41,428	-137 Reduced 32.39%	286 $61,000
Q1 2022 May 10, 2022	SELL	$255.51 - $362.11 $287,959 - $408,097	-1,127 Reduced 72.71%	423 $120,000
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $56,572 - $72,237	-161 Reduced 9.41%	1,550 $585,000
Q3 2021 Nov 08, 2021	SELL	$372.64 - $458.3 $282,461 - $347,391	-758 Reduced 30.7%	1,711 $707,000
Q2 2021 Aug 09, 2021	BUY	$294.17 - $371.65 $6,471 - $8,176	22 Added 0.9%	2,469 $913,000
Q1 2021 Apr 28, 2021	BUY	$249.67 - $299.48 $599,457 - $719,051	2,401 Added 5219.57%	2,447 $710,000
Q4 2020 Feb 09, 2021	SELL	$222.0 - $252.62 $667,110 - $759,123	-3,005 Reduced 98.49%	46 $11,000
Q3 2020 Nov 02, 2020	BUY	$175.56 - $226.45 $394,658 - $509,059	2,248 Added 279.95%	3,051 $692,000
Q2 2020 Aug 11, 2020	SELL	$118.84 - $189.72 $2,614 - $4,173	-22 Reduced 2.67%	803 $140,000
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $39,658 - $71,514	401 Added 94.58%	825 $105,000
Q4 2019 Feb 13, 2020	BUY	$126.05 - $152.76 $630 - $763	5 Added 1.19%	424 $65,000
Q3 2019 Oct 17, 2019	BUY	$125.07 - $143.67 $1,375 - $1,580	11 Added 2.7%	419 $56,000
Q2 2019 Aug 05, 2019	BUY	$123.4 - $148.55 $987 - $1,188	8 Added 2.0%	408 $58,000
Q1 2019 Apr 16, 2019	SELL	$104.82 - $146.73 $103,771 - $145,262	-990 Reduced 71.22%	400 $58,000
Q4 2018 Jan 17, 2019	BUY	$105.09 - $137.23 $55,067 - $71,908	524 Added 60.51%	1,390 $157,000
Q3 2018 Nov 02, 2018	BUY	$112.11 - $134.54 $20,628 - $24,755	184 Added 26.98%	866 $0
Q2 2018 Jul 24, 2018	SELL	$102.37 - $117.25 $5,425 - $6,214	-53 Reduced 7.21%	682 $0
Q1 2018 May 03, 2018	SELL	$98.19 - $115.2 $86,014 - $100,915	-876 Reduced 54.38%	735 $78,000
Q4 2017 Feb 02, 2018	SELL	$100.43 - $118.09 $415,679 - $488,774	-4,139 Reduced 71.98%	1,611 $176,000
Q3 2017 Oct 20, 2017	BUY	$96.72 - $109.26 $556,140 - $628,245	5,750	5,750 $622,000

Others Institutions Holding CRL

# of Institutions

710

Shares Held

49.8M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.66B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Charles River Laboratories International, Inc. Transaction History